# Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy

> **NCT01521611** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 62 (actual)

## Conditions studied

- Acute Leukaemia
- Chronic Leukaemia
- Myeloma
- Lymphoma

## Interventions

- **RADIATION:** Targeted radiotherapy

## Key facts

- **NCT ID:** NCT01521611
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2017-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2019-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521611, "Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01521611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*